Prognosis prediction of uterine cervical cancer using changes in the histogram and texture features of apparent diffusion coefficient during definitive chemoradiotherapy
Open Access
- 31 March 2023
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (3) , e0282710
Abstract
Objectives: We investigated prospectively whether, in cervical cancer (CC) treated with concurrent chemoradiotherapy (CCRT), the Apparent diffusion coefficient (ADC) histogram and texture parameters and their change rates during treatment could predict prognosis. Methods: Fifty-seven CC patients treated with CCRT at our institution were included. They underwent MRI scans up to four times during the treatment course (1st, before treatment [n = 41], 2nd, at the start of image-guided brachytherapy (IGBT) [n = 41], 3rd, in the middle of IGBT [n = 27], 4th, after treatment [n = 53]). The entire tumor was manually set as the volume of interest (VOI) manually in the axial images of the ADC map by two radiologists. A total of 107 image features (morphology features 14, histogram features 18, texture features 75) were extracted from the VOI. The recurrence prediction values of the features and their change rates were evaluated by Receiver operating characteristics (ROC) analysis. The presence or absence of local and distant recurrence within two years was set as an outcome. The intraclass correlation coefficient (ICC) was also calculated. Results: The change rates in kurtosis between the 1st and 3rd, and 1st and 2nd MRIs, and the change rate in grey level co-occurrence matrix_cluster shade between the 2nd and 3rd MRIs showed particularly high predictive powers (area under the ROC curve = 0.785, 0.759, and 0.750, respectively), which exceeded the predictive abilities of the parameters obtained from pre- or post-treatment MRI only. The change rate in kurtosis between the 1st and 2nd MRIs had good reliability (ICC = 0.765). Conclusions: The change rate in ADC kurtosis between the 1st and 2nd MRIs was the most reliable parameter, enabling us to predict prognosis early in the treatment course.Keywords
Funding Information
- Japan Society for the Promotion of Science (JSPS) Kakenhi (JP20K16752)
This publication has 31 references indexed in Scilit:
- Post–Radiation Therapy Imaging Appearances in Cervical CarcinomaRadioGraphics, 2016
- Daily Low-Dose Cisplatin-Based Concurrent Chemoradiotherapy for the Treatment of Cervical Cancer in Patients 70 Years or OlderInternational Journal of Gynecological Cancer, 2015
- Improved survival of patients with cervical cancer treated with image-guided brachytherapy compared with conventional brachytherapyGynecologic Oncology, 2014
- Histogram analysis of apparent diffusion coefficient for the assessment of local aggressiveness of cervical cancerArchives of Gynecology and Obstetrics, 2014
- Predictive value of diffusion‐weighted magnetic resonance imaging during chemoradiotherapy for uterine cervical cancerJournal of Obstetrics and Gynaecology Research, 2013
- Pre-Treatment Diffusion-Weighted MR Imaging for Predicting Tumor Recurrence in Uterine Cervical Cancer Treated with Concurrent Chemoradiation: Value of Histogram Analysis of Apparent Diffusion CoefficientsKorean Journal of Radiology, 2013
- Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice?Insights into Imaging, 2012
- Pelvic Imaging Following Chemotherapy and Radiation Therapy for Gynecologic MalignanciesRadioGraphics, 2010
- Recommendations from gynaecological (GYN) GEC ESTRO working group (II): Concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy—3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiologyRadiotherapy and Oncology, 2006
- Morphometric analysis of white matter lesions in MR images: method and validationIEEE Transactions on Medical Imaging, 1994